Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Clinical Microbiology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Special Issue Letter to the Editor

Evaluation of a Rapid Diagnostic Assay for Detection of SARS-CoV-2 Antigen in Nasopharyngeal Swabs

Sidonie Lambert-Niclot, Alexis Cuffel, Samuel Le Pape, Christelle Vauloup-Fellous, Laurence Morand-Joubert, Anne-Marie Roque-Afonso, Jérôme Le Goff, Constance Delaugerre
Alexander J. McAdam, Editor
Sidonie Lambert-Niclot
aINSERM-Sorbonne Universités UPMC, Université Paris 06, UMR-S 1136, Institut Pierre Louis d’Epidémiologie et de Santé Publique (iPLESP), Paris, France
bHôpital Saint-Antoine, Laboratoire de Virologie, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexis Cuffel
cHôpital Saint Louis, Laboratoire de Virologie, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Samuel Le Pape
dService de Virologie, Hôpital Paul-Brousse, INSERM U 1193, Université Paris-Saclay Villejuif, APHP Paris-Saclay, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christelle Vauloup-Fellous
dService de Virologie, Hôpital Paul-Brousse, INSERM U 1193, Université Paris-Saclay Villejuif, APHP Paris-Saclay, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laurence Morand-Joubert
aINSERM-Sorbonne Universités UPMC, Université Paris 06, UMR-S 1136, Institut Pierre Louis d’Epidémiologie et de Santé Publique (iPLESP), Paris, France
bHôpital Saint-Antoine, Laboratoire de Virologie, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anne-Marie Roque-Afonso
dService de Virologie, Hôpital Paul-Brousse, INSERM U 1193, Université Paris-Saclay Villejuif, APHP Paris-Saclay, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jérôme Le Goff
cHôpital Saint Louis, Laboratoire de Virologie, Paris, France
eUniversité de Paris, INSERM U976, Team Insight, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Constance Delaugerre
cHôpital Saint Louis, Laboratoire de Virologie, Paris, France
fINSERM U944, Université de Paris, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexander J. McAdam
Boston Children's Hospital
Roles: Editor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/JCM.00977-20
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

LETTER

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus causing coronavirus disease 2019 (COVID-19), was reported for the first time in Wuhan (Hubei Province, China) in December 2019 (1, 2) and has become a major public health concern all over the world. Early diagnosis is crucial for patient management and outbreak control. Most tests currently used for the detection of SARS-CoV-2 rely on viral RNA amplification by using real-time PCR (RT-PCR) and require a few hours before result release. Hence, highly sensitive immunological diagnostic methods that directly detect viral antigens in clinical samples would be very helpful for rapid and accurate diagnosis of COVID-19.

Here, we evaluated a rapid diagnostic test, COVID-19 Ag Respi-Strip (Coris BioConcept, Gembloux, Belgium), for detection of the SARS-CoV-2 antigen in nasopharyngeal secretions. The assay is ready to use and based on a nitrocellulose membrane technology with colloidal gold nanoparticles sensitized with monoclonal antibodies directed against highly conserved SARS-CoV-2 nucleoprotein antigens. We compared this test with RT-PCR, the current reference assay in virology laboratories of three university hospital groups from Assistance-Publique-Hôpitaux de Paris (APHP) (Saint-Antoine-Tenon-Trousseau, Saint-Louis-Lariboisière, and Kremlin Bicêtre-Paul Brousse). Different RT-PCR methods were used (RealStar [Altona Diagnostics], Bosphore novel coronavirus (2019-nCoV) detection kit [Anatolia Geneworks], Cobas 6800 [Roche], Allplex 2019 novel CoV assay [Seegene]). All assays amplify the SARS-CoV-2 E gene. Cycle threshold (CT) values were recorded. Nasopharyngeal samples were tested prospectively within a few hours after collection and without any cooling or freezing step, from 1 April to 15 April 2020. Swabs were collected in various transport media (COPAN’s UTM [3 ml], Virocult [1 ml], ESwab Amies [1 ml], 4MRT [3 ml], 0.9% NaCl buffer, and cobas [Roche]). The first four samples collected in cobas medium tested gave invalid results. We therefore excluded such samples from the study. Our analysis included 138 nasopharyngeal samples, of which 94 (68.8%) were positive for SARS-CoV-2 by RT-PCR. Compared to that of RT-PCR, the specificity of the test was 100% (95% confidence intervals [95% CI], 91.8 to 100). Among the 94 RT-PCR-positive samples, the rapid test detected only 47 specimens, resulting in a sensitivity of 50.0% (95 CI, 39.5 to 60.5). In nine positive and eight negative tests, control lines were barely visible. Medians of E gene CT values differed significantly between positive (median = 21; interquartile range [IQR], 17.0 to 23.0) and negative (median = 28.3; IQR, 25.6 to 33.0) antigenic test results (P < 0.0001) (Fig. 1). A study conducted by the manufacturer mentioned a sensitivity of 76.7% for samples positive with a CT value under 25 (3). In our study, the test had a sensitivity of 82.2% for CT values under 25.

FIG 1
  • Open in new tab
  • Download powerpoint
FIG 1

COVID-19 Ag Respi-Strip (Coris) results according to real-time PCR CT values. All cycle threshold values of E gene real-time PCR-positive assays are shown for positive and negative COVID-19 Ag Respi-Strip assay results. Results gathering CT values for all real-time PCR-positive assays are depicted by squares. CT values between samples positive or negative for the antigenic assay are significantly different (* indicates a P value of <0.0001). CT values corresponding to the Cobas 6800, Allplex, Anatolia, and RealStar assays are depicted by triangles, diamonds, circles, and upside-down triangles, respectively.

In our study, the COVID-19 Ag Respi-Strip (Coris) had a sensitivity of 50% compare to that of RT-PCR. The test was more sensitive for high viral loads and might perhaps be used for patients within a few days after symptom onset, when the load in the upper respiratory tract is at its peak. Considering COVID-19’s current low prevalence of 0.19% in France, prospective studies should be conducted to determine the best settings for its implementation.

  • Copyright © 2020 American Society for Microbiology.

All Rights Reserved.

REFERENCES

  1. 1.↵
    1. Huang C,
    2. Wang Y,
    3. Li X,
    4. Ren L,
    5. Zhao J,
    6. Hu Y,
    7. Zhang L,
    8. Fan G,
    9. Xu J,
    10. Gu X,
    11. Cheng Z,
    12. Yu T,
    13. Xia J,
    14. Wei Y,
    15. Wu W,
    16. Xie X,
    17. Yin W,
    18. Li H,
    19. Liu M,
    20. Xiao Y,
    21. Gao H,
    22. Guo L,
    23. Xie J,
    24. Wang G,
    25. Jiang R,
    26. Gao Z,
    27. Jin Q,
    28. Wang J,
    29. Cao B
    . 2020. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395:497–506. doi:10.1016/S0140-6736(20)30183-5.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Zhu N,
    2. Zhang D,
    3. Wang W,
    4. Li X,
    5. Yang B,
    6. Song J,
    7. Zhao X,
    8. Huang B,
    9. Shi W,
    10. Lu R,
    11. Niu P,
    12. Zhan F,
    13. Ma X,
    14. Wang D,
    15. Xu W,
    16. Wu G,
    17. Gao GF,
    18. Tan W
    , China Novel Coronavirus Investigating and Research Team. 2020. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 382:727–733. doi:10.1056/NEJMoa2001017.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Mertens P,
    2. De Voe N,
    3. Martiny D,
    4. Jassoy C,
    5. Mirazimi A,
    6. Cuypers L,
    7. Van den Wijngaert S,
    8. Monteil V,
    9. Melin P,
    10. Stoffels K,
    11. Yin N,
    12. Mileto D,
    13. Delaunoy S,
    14. Magein H,
    15. Lagrou K,
    16. Bouzet J,
    17. Serrano G,
    18. Wautier M,
    19. Leclipteux T,
    20. Van Ranst M,
    21. Vandenberg O
    , LHUB-ULB SARS-CoV-2 Working Diagnostic Group. 8 May 2020. Development and potential usefulness of the COVID-19 Ag Respi-Strip diagnostic assay in a pandemic context. Front Med https://www.frontiersin.org/articles/10.3389/fmed.2020.00225/full?&utm_source=Email_to_authors_&utm_medium=Email&utm_content=T1_11.5e1_author&utm_campaign=Email_publication&field=&journalName=Frontiers_in_Medicine&id=551560.
PreviousNext
Back to top
Download PDF
Citation Tools
Evaluation of a Rapid Diagnostic Assay for Detection of SARS-CoV-2 Antigen in Nasopharyngeal Swabs
Sidonie Lambert-Niclot, Alexis Cuffel, Samuel Le Pape, Christelle Vauloup-Fellous, Laurence Morand-Joubert, Anne-Marie Roque-Afonso, Jérôme Le Goff, Constance Delaugerre on behalf of the AP-HP/Universities/INSERMCOVID-19 Research Collaboration
Journal of Clinical Microbiology Jul 2020, 58 (8) e00977-20; DOI: 10.1128/JCM.00977-20

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Clinical Microbiology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Evaluation of a Rapid Diagnostic Assay for Detection of SARS-CoV-2 Antigen in Nasopharyngeal Swabs
(Your Name) has forwarded a page to you from Journal of Clinical Microbiology
(Your Name) thought you would be interested in this article in Journal of Clinical Microbiology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Evaluation of a Rapid Diagnostic Assay for Detection of SARS-CoV-2 Antigen in Nasopharyngeal Swabs
Sidonie Lambert-Niclot, Alexis Cuffel, Samuel Le Pape, Christelle Vauloup-Fellous, Laurence Morand-Joubert, Anne-Marie Roque-Afonso, Jérôme Le Goff, Constance Delaugerre on behalf of the AP-HP/Universities/INSERMCOVID-19 Research Collaboration
Journal of Clinical Microbiology Jul 2020, 58 (8) e00977-20; DOI: 10.1128/JCM.00977-20
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • LETTER
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

antigen
SARS-CoV-2
rapid diagnostic test

Related Articles

Cited By...

About

  • About JCM
  • Editor in Chief
  • Board of Editors
  • Editor Conflicts of Interest
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Resources for Clinical Microbiologists
  • Ethics
  • Contact Us

Follow #JClinMicro

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

 

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0095-1137; Online ISSN: 1098-660X